181 related articles for article (PubMed ID: 29087398)
1. Risk of Clostridium difficile Infection in Patients With Celiac Disease: A Population-Based Study.
Lebwohl B; Nobel YR; Green PHR; Blaser MJ; Ludvigsson JF
Am J Gastroenterol; 2017 Dec; 112(12):1878-1884. PubMed ID: 29087398
[TBL] [Abstract][Full Text] [Related]
2. Association Between Celiac Disease and Mortality Risk in a Swedish Population.
Lebwohl B; Green PHR; Söderling J; Roelstraete B; Ludvigsson JF
JAMA; 2020 Apr; 323(13):1277-1285. PubMed ID: 32259229
[TBL] [Abstract][Full Text] [Related]
3. Clinical predictors of recurrent Clostridium difficile infection in out-patients.
Shivashankar R; Khanna S; Kammer PP; Scott Harmsen W; Zinsmeister AR; Baddour LM; Pardi DS
Aliment Pharmacol Ther; 2014 Sep; 40(5):518-22. PubMed ID: 25039269
[TBL] [Abstract][Full Text] [Related]
4. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer.
de Blank P; Zaoutis T; Fisher B; Troxel A; Kim J; Aplenc R
J Pediatr; 2013 Sep; 163(3):699-705.e1. PubMed ID: 23477996
[TBL] [Abstract][Full Text] [Related]
5. Association of Household Exposure to Primary Clostridioides difficile Infection With Secondary Infection in Family Members.
Miller AC; Segre AM; Pemmaraju SV; Sewell DK; Polgreen PM
JAMA Netw Open; 2020 Jun; 3(6):e208925. PubMed ID: 32589232
[TBL] [Abstract][Full Text] [Related]
6. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.
Marwick CA; Yu N; Lockhart MC; McGuigan CC; Wiuff C; Davey PG; Donnan PT
J Antimicrob Chemother; 2013 Dec; 68(12):2927-33. PubMed ID: 23825381
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile infection and risk of Parkinson's disease: a Swedish population-based cohort study.
Kang X; Ploner A; Ludvigsson JF; Williams DM; Larsson H; Pedersen NL; Wirdefeldt K
Eur J Neurol; 2020 Nov; 27(11):2134-2141. PubMed ID: 32538502
[TBL] [Abstract][Full Text] [Related]
8. Trends and Predictors of Clostridium difficile Infection among Children: A Canadian Population-Based Study.
El-Matary W; Nugent Z; Yu BN; Lix LM; Targownik LE; Bernstein CN; Singh H
J Pediatr; 2019 Mar; 206():20-25. PubMed ID: 30448272
[TBL] [Abstract][Full Text] [Related]
9. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
[TBL] [Abstract][Full Text] [Related]
10. National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals.
Pechal A; Lin K; Allen S; Reveles K
BMC Infect Dis; 2016 Nov; 16(1):682. PubMed ID: 27855653
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and risk factors for Clostridium difficile infection in children.
Sandora TJ; Fung M; Flaherty K; Helsing L; Scanlon P; Potter-Bynoe G; Gidengil CA; Lee GM
Pediatr Infect Dis J; 2011 Jul; 30(7):580-4. PubMed ID: 21233782
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and genomic characterization of community-acquired Clostridium difficile infections.
Thornton CS; Rubin JE; Greninger AL; Peirano G; Chiu CY; Pillai DR
BMC Infect Dis; 2018 Aug; 18(1):443. PubMed ID: 30170546
[TBL] [Abstract][Full Text] [Related]
13. Regional and seasonal variation in Clostridium difficile infections among hospitalized patients in the United States, 2001-2010.
Argamany JR; Aitken SL; Lee GC; Boyd NK; Reveles KR
Am J Infect Control; 2015 May; 43(5):435-40. PubMed ID: 25952045
[TBL] [Abstract][Full Text] [Related]
14. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
Freedberg DE; Salmasian H; Friedman C; Abrams JA
Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
[TBL] [Abstract][Full Text] [Related]
16. National Surveillance for Clostridioides difficile Infection, Sweden, 2009-2016.
Rizzardi K; Norén T; Aspevall O; Mäkitalo B; Toepfer M; Johansson Å; Åkerlund T
Emerg Infect Dis; 2018 Sep; 24(9):1617-1625. PubMed ID: 30124193
[TBL] [Abstract][Full Text] [Related]
17. Small-intestinal histopathology and mortality risk in celiac disease.
Ludvigsson JF; Montgomery SM; Ekbom A; Brandt L; Granath F
JAMA; 2009 Sep; 302(11):1171-8. PubMed ID: 19755695
[TBL] [Abstract][Full Text] [Related]
18. Risk of bacterial pneumonia and pneumococcal infection in youths with celiac disease - A population-based study.
Canova C; Ludvigsson J; Baldo V; Barbiellini Amidei C; Zanier L; Zingone F
Dig Liver Dis; 2019 Aug; 51(8):1101-1105. PubMed ID: 30926284
[TBL] [Abstract][Full Text] [Related]
19. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
Singh H; Nugent Z; Yu BN; Lix LM; Targownik LE; Bernstein CN
Gastroenterology; 2017 Aug; 153(2):430-438.e2. PubMed ID: 28479377
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease.
Reilly NR; Lebwohl B; Hultcrantz R; Green PH; Ludvigsson JF
J Hepatol; 2015 Jun; 62(6):1405-11. PubMed ID: 25617505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
